Partnering with SBP provides access to deep biological insights and cutting edge translational technology.
Science Benefiting patients
At Sanford Burnham Prebys Medical Discovery Institute (SBP) we take a multi-disciplinary approach
Partner of Choice
- Faculty, staff scientists, postdoctoral fellows, graduate students and support staff – who work collaboratively for the benefit of patients
- Deep biological insight to pathways and targets
- Experiments done right the ﬁrst time
- Timelines and Go/No-go decision points
- Pharma-grade drug discovery
- Non-bureaucratic, collaborative, trusted way of working
- Mission focused organization - Not-for-proﬁt independent research institute
- Fair IP strategy
- First-in-class projects
- Unique technologies
- Diverse types of relationships
Partnering In Early Stage R&D
At Sanford Burnham Prebys Medical Discovery Institute, we bring together both fundamental biomedical research and robust drug discovery capabilities in pursuit of translational medicine. Collaborative relationships provide our partners direct access to the knowledge, capabilities and expertise in the Institute’s core research areas of cancer, neuroscience, immunity, metabolic disorders and rare diseases. Building on this foundation of biology expertise and disease research, SBP has extensive drug discovery capabilities, providing the means to turn biological insight into novel drug candidates.
Drug Discovery Pipeline
We aim to discover and develop first in class novel therapeutics. Through our drug discovery programs at the Prebys Center and the Translational Medicine Accelerator, we have established a broad pipeline of novel programs ranging from discovery to lead optimization and candidate selection in SBP’s core research areas of cancer, neuroscience, immunity, metabolic disorders and rare diseases. We seek partnerships to collaboratively develop these new medicines. We partner with most large pharma, many biotechs, disease foundations, government agencies, and other institutions.
We prioritize maintaining robust relationships with our partners. The Strategic Alliance group ensures that collaborations with partner organizations are well managed. We help leadership tap into sources of innovation within the Institute, identify ways they could align with the interests of biotech and pharma, and communicate the potential benefits of joining forces. When new partnerships are solidified, we help negotiate contracts, establish governance and determine the cadence for each project to ensure that all involved have similar expectations of outcomes and timelines.